RESUMO
The development of the visual system is a complex and multi-step process characterized by the precise wiring of retinal ganglion cell (RGC) axon terminals with their corresponding neurons in the visual nuclei of the brain. Upon reaching primary image-forming nuclei (IFN), such as the superior colliculus and the lateral geniculate nucleus, RGC axons undergo extensive arborization that refines over the first few postnatal weeks. The molecular mechanisms driving this activity-dependent remodeling process, which is influenced by waves of spontaneous activity in the developing retina, are still not well understood. In this study, by manipulating the activity of RGCs in mice from either sex and analyzing their transcriptomic profiles before eye opening, we identified the type I membrane protein Synaptotagmin 13 (Syt13) as involved in spontaneous activity-dependent remodeling. Using these mice, we also explored the impact of spontaneous retinal activity on the development of other RGC recipient targets such as non-image forming (NIF) nuclei and demonstrate that proper frequency and duration of retinal waves occurring prior to visual experience are essential for shaping the connectivity of the NIF circuit. Together, these findings contribute to a deeper understanding of the molecular and physiological mechanisms governing activity-dependent axon refinement during the assembly of the visual circuit.Significance statement Waves of correlated activity spontaneously triggered in the retina during perinatal stages play a crucial role in establishing topographic maps and eye-specific segregation in image-forming brain nuclei, contributing to proper adult visual function. Here, we analyze visual nuclei that lack topography and other typical characteristics, referred to as non-image-forming nuclei, in mice with altered retinal waves and found that retinal waves significantly influence the assembly of these circuits. Furthermore, by analyzing the transcriptomic profiles of retinal ganglion cells from mice with modified retinal activity, we identified novel players implicated in spontaneous activity-dependent refinement. This research provides valuable insights into the molecular and physiological mechanisms that govern the precise wiring of the visual circuitry.
RESUMO
The regenerative activity of adult stem cells carries a risk of cancer, particularly in highly renewable tissues. Members of the family of inhibitor of apoptosis proteins (IAPs) inhibit caspases and cell death, and are often deregulated in adult cancers; however, their roles in normal adult tissue homeostasis are unclear. Here, we show that regulation of the number of enterocyte-committed progenitor (enteroblast) cells in the adult Drosophila involves a caspase-mediated physiological apoptosis, which adaptively eliminates excess enteroblast cells produced by intestinal stem cells (ISCs) and, when blocked, can also lead to tumorigenesis. Importantly, we found that Diap1 is expressed by enteroblast cells and that loss and gain of Diap1 led to changes in enteroblast numbers. We also found that antagonistic interplay between Notch and EGFR signalling governs enteroblast life/death decisions via the Klumpfuss/WT1 and Lozenge/RUNX transcription regulators, which also regulate enteroblast differentiation and cell fate plasticity. These data provide new insights into how caspases drive adult tissue renewal and protect against the formation of tumours.
Assuntos
Apoptose , Proteínas de Drosophila/metabolismo , Drosophila melanogaster/fisiologia , Enterócitos/patologia , Receptores ErbB/metabolismo , Intestinos/patologia , Receptores de Peptídeos de Invertebrados/metabolismo , Receptores Notch/metabolismo , Células-Tronco/patologia , Animais , Caspases , Diferenciação Celular , Linhagem da Célula , Proteínas de Drosophila/genética , Enterócitos/metabolismo , Receptores ErbB/genética , Feminino , Homeostase , Proteínas Inibidoras de Apoptose/genética , Proteínas Inibidoras de Apoptose/metabolismo , Masculino , Receptores de Peptídeos de Invertebrados/genética , Receptores Notch/genética , Transdução de Sinais , Células-Tronco/metabolismoRESUMO
The α7 nicotinic acetylcholine receptor (α7 nAChR) is a ligand-gated ion channel that is involved in cognition disorders, schizophrenia, pain, and inflammation. Allosteric modulation of this receptor might be advantageous to reduce the toxicity in comparison with full agonists. Our previous results obtained with some hydroxy-chalcones, which were identified as positive allosteric modulators (PAMs) of α7 nAChR, prompted us to evaluate the potential of some structurally related naturally occurring flavonoids and curcuminoids and some synthetic curcumin analogues, with the aim of identifying new allosteric modulators of the α7 nAChR. Biological evaluation showed that phloretin, demethoxycurcumin, and bis-demethoxicurcuming behave as PAMs of α7 nAChR. In addition, some new curcumin derivatives were able to enhance the signal evoked by ACh; the activity values found for the tetrahydrocurcuminoid analog 23 were especially promising.
Assuntos
Diarileptanoides/farmacologia , Flavonoides/farmacologia , Receptor Nicotínico de Acetilcolina alfa7/agonistas , Regulação Alostérica/efeitos dos fármacos , Animais , Produtos Biológicos/farmacologia , Curcumina/análogos & derivados , Curcumina/síntese química , Curcumina/farmacologia , Diarileptanoides/química , Relação Dose-Resposta a Droga , Fenômenos Eletrofisiológicos/efeitos dos fármacos , Potenciais Evocados/efeitos dos fármacos , Feminino , Xenopus laevisRESUMO
BACKGROUND AND PURPOSE: The mechanistic target of rapamycin (mTOR) signalling pathway is a key regulator of cell growth and metabolism. Its deregulation is implicated in several diseases. The macrolide rapamycin, a specific inhibitor of mTOR, has immunosuppressive, anti-inflammatory and antiproliferative properties. Recently, we identified tacrolimus, another macrolide immunosuppressant, as a novel activator of TRPM8 ion channels, involved in cold temperature sensing, thermoregulation, tearing and cold pain. We hypothesized that rapamycin may also have agonist activity on TRPM8 channels. EXPERIMENTAL APPROACH: Using calcium imaging and electrophysiology in transfected HEK293 cells and wildtype or Trpm8 KO mouse DRG neurons, we characterized rapamycin's effects on TRPM8 channels. We also examined the effects of rapamycin on tearing in mice. KEY RESULTS: Micromolar concentrations of rapamycin activated rat and mouse TRPM8 channels directly and potentiated cold-evoked responses, effects also observed in human TRPM8 channels. In cultured mouse DRG neurons, rapamycin increased intracellular calcium levels almost exclusively in cold-sensitive neurons. Responses were markedly decreased in Trpm8 KO mice or by TRPM8 channel antagonists. Cutaneous cold thermoreceptor endings were also activated by rapamycin. Topical application of rapamycin to the eye surface evokes tearing in mice by a TRPM8-dependent mechanism. CONCLUSION AND IMPLICATIONS: These results identify TRPM8 cationic channels in sensory neurons as novel molecular targets of the immunosuppressant rapamycin. These findings may help explain some of its therapeutic effects after topical application to the skin and the eye surface. Moreover, rapamycin could be used as an experimental tool in the clinic to explore cold thermoreceptors.
Assuntos
Imunossupressores , Camundongos Knockout , Células Receptoras Sensoriais , Sirolimo , Canais de Cátion TRPM , Canais de Cátion TRPM/antagonistas & inibidores , Canais de Cátion TRPM/metabolismo , Animais , Humanos , Células HEK293 , Sirolimo/farmacologia , Células Receptoras Sensoriais/efeitos dos fármacos , Células Receptoras Sensoriais/metabolismo , Imunossupressores/farmacologia , Ratos , Camundongos , Masculino , Camundongos Endogâmicos C57BL , Células Cultivadas , Cálcio/metabolismo , Gânglios Espinais/efeitos dos fármacos , Gânglios Espinais/metabolismo , Temperatura BaixaRESUMO
Although α7 nicotinic receptors are predominantly homopentamers, previous reports have indicated that α7 and ß2 subunits are able to form heteromers. We have studied whether other nicotinic receptor subunits can also assemble with α7 subunits and the effect of this potential association. Coexpression of α7 with α2, α3, or ß4 subunits reduced to about half, surface α-bungarotoxin binding sites and acetylcholine-gated currents. This is probably because of inhibition of membrane trafficking, as the total amount of α7 subunits was similar in all cases and a significant proportion of mature α7 receptors was present inside the cell. Only ß4 subunits appeared to directly associate with α7 receptors at the membrane and these heteromeric receptors showed some kinetic and pharmacological differences when compared with homomeric α7 receptors. Finally, we emulated the situation of bovine chromaffin cells in Xenopus laevis oocytes by using the same proportion of α3, ß4, α5, and α7 mRNAs, finding that α-bungarotoxin binding was similarly reduced in spite of increased currents, apparently mediated by α3ß4(α5) receptors.
Assuntos
Regulação da Expressão Gênica/fisiologia , Subunidades Proteicas/metabolismo , Receptores Nicotínicos/metabolismo , Acetilcolina/farmacologia , Análise de Variância , Animais , Biofísica , Bungarotoxinas/farmacocinética , Bovinos , Células Cultivadas , Colina/farmacologia , Colinérgicos/farmacologia , Células Cromafins , Estimulação Elétrica , Regulação da Expressão Gênica/genética , Proteínas de Fluorescência Verde/genética , Humanos , Isótopos de Iodo/farmacocinética , Larva , Lipotrópicos/farmacologia , Potenciais da Membrana/efeitos dos fármacos , Potenciais da Membrana/genética , Microinjeções , Oócitos , Técnicas de Patch-Clamp , Ligação Proteica/efeitos dos fármacos , Ligação Proteica/fisiologia , Subunidades Proteicas/genética , RNA Mensageiro/metabolismo , Receptores Nicotínicos/genética , Xenopus , Receptor Nicotínico de Acetilcolina alfa7RESUMO
We have studied the role of loop 9 in the function of neuronal nicotinic receptors. By systematically mutating the residues in the loop we have determined that the most important amino acids determining the coupling of binding to gating are the ones closer to the transmembrane region. Single mutations at location E173 in homomeric alpha7 receptors destroyed their function by completely abolishing the current while preserving the expression at the membrane. In contrast, heteromeric receptor alpha3beta4 with the same mutations retained some function. We conclude that loop 9 has a different role in the function of homomeric and heteromeric receptors.
Assuntos
Neurônios/metabolismo , Receptores Nicotínicos/química , Receptores Nicotínicos/metabolismo , Acetilcolina/farmacologia , Alanina/genética , Animais , Bovinos , Humanos , Ativação do Canal Iônico/efeitos dos fármacos , Mutagênese/efeitos dos fármacos , Proteínas Mutantes/metabolismo , Mutação/genética , Multimerização Proteica , Estrutura Secundária de Proteína , Ratos , Relação Estrutura-Atividade , Xenopus laevisRESUMO
We have studied the role of different amino acids in the M2 transmembrane domain of the α7 neuronal nicotinic receptor by mutating residues that differ from the ones located at the same positions in other α (α2-α10) or ß (ß2-ß4) subunits. Our aim was to investigate the contribution of these amino acids to the peculiar kinetic and inward rectification properties that differentiate the homomeric α7 receptor from other nicotinic receptors. Mutations of several residues strongly modified receptor function. We found that Thr245 had the most profound effect when mutated to serine, an amino acid present in all heteromeric receptors composed of α and ß subunits, by dramatically increasing the maximal current, decreasing the decaying rate of the currents and decreasing receptor rectification. Some mutants also showed altered agonist-binding properties as revealed by shifts in the dose-response curves for acetylcholine. We conclude that residues in the M2 segment and flanking regions contribute to the unusual properties of the α7 receptor, especially to its characteristic fast kinetic behavior and strong inward rectification and furthermore to the potency of agonists.
Assuntos
Ativação do Canal Iônico/fisiologia , Receptores Nicotínicos/metabolismo , Acetilcolina/metabolismo , Algoritmos , Sequência de Aminoácidos , Substituição de Aminoácidos , Animais , Bungarotoxinas/metabolismo , Bovinos , DNA Complementar/biossíntese , DNA Complementar/genética , Fenômenos Eletrofisiológicos , Ativação do Canal Iônico/genética , Cinética , Potenciais da Membrana/fisiologia , Modelos Moleculares , Dados de Sequência Molecular , Oócitos/efeitos dos fármacos , Oócitos/metabolismo , Técnicas de Patch-Clamp , Ligação Proteica , Receptor Muscarínico M2/efeitos dos fármacos , Receptor Muscarínico M2/metabolismo , Receptores Nicotínicos/genética , Xenopus laevis , Receptor Nicotínico de Acetilcolina alfa7RESUMO
Activation of nicotinic acetylcholine receptors (nAChR) requires a global conformational change involving a number of domains of the protein. Structural data from Torpedo nAChR suggest that adjacent subunits might be functionally coupled at the interface between the ß-strand ß3 and the loop B through a salt bridge between α1Asp152 and γArg78. We have checked this hypothesis in homomeric α7 nAChRs by mutating residues at these (Gly152 and Arg79) and neighboring locations and analyzing the results obtained after expression of single and double mutants in Xenopus oocytes. We found that Arg79 mutants showed a decreased gating function when challenged with different agonists, being the reduction more important for dimethylphenylpiperazinium. EC(50) values in these mutants were also increased up to 30-fold. In contrast, mutating Gly152 only showed significant higher EC(50) values for ACh. However, all Gly153 mutants presented increased gating function and lower EC(50) values with no significant differences among them. When analyzing several mutant cycles it is concluded that Arg79 is functionally coupled to Gly152, but neither to Gly153 nor to Asp157. These data suggest an involvement of the minus side of homomeric α7 nAChRs in their gating function, reinforcing the significance of complementary subunits in the gating of neuronal nAChRs.
Assuntos
Receptores Nicotínicos/genética , Receptores Nicotínicos/metabolismo , Substituição de Aminoácidos , Animais , Compostos Bicíclicos Heterocíclicos com Pontes/farmacologia , Bovinos , DNA Complementar/genética , Interpretação Estatística de Dados , Iodeto de Dimetilfenilpiperazina/farmacologia , Fenômenos Eletrofisiológicos , Humanos , Ativação do Canal Iônico/efeitos dos fármacos , Ativação do Canal Iônico/genética , Modelos Moleculares , Mutação/genética , Mutação/fisiologia , Agonistas Nicotínicos/farmacologia , Oócitos/efeitos dos fármacos , Piridinas/farmacologia , RNA Mensageiro/biossíntese , RNA Mensageiro/genética , Receptores Nicotínicos/efeitos dos fármacos , Torpedo/genética , Torpedo/metabolismo , Xenopus laevis , Receptor Nicotínico de Acetilcolina alfa7RESUMO
The highly conserved alphaLys145 has been suggested to play an important role in the early steps of activation of the nicotinic acetylcholine receptor (nAChR) by acetylcholine. Both macroscopic and single channel currents were recorded in the slowly desensitizing mutants L248T- and K145A-L248T-alpha7 receptors expressed in Xenopus oocytes. On ACh-evoked currents, substitution of Lys145 by alanine showed the same effects that in wild type receptors: moderately decreased gating function and a more-than-expected loss of ACh potency, thus validating the experimental model. Single channel analysis quantitatively agreed with macroscopic data and revealed that impaired gating function in the double mutant alpha7K145A/L248T is the consequence of a slower opening rate, beta. Several nicotinic agonists were also studied, showing important features. Particularly, dimethylphenylpiperazinium (DMPP), acting as an antagonist in alpha7K145A, became a full agonist in alpha7K145A/L248T. Single channel analysis of DMPP-evoked currents showed effects of Lys145 removal similar to those observed with ACh. Data suggest that alpha7Lys145 facilitates the early steps of channel activation. Moreover, the slowly desensitizing mutant alpha7L248T could be an interesting tool for the study of channel activation in alpha7 receptors. Nevertheless, its extensively altered pharmacology precludes the simple extrapolation of pharmacological data obtained in singly mutated alpha7 receptors.
Assuntos
Ativação do Canal Iônico/efeitos dos fármacos , Antagonistas Nicotínicos/farmacologia , Receptores Nicotínicos/metabolismo , Acetilcolina/metabolismo , Animais , Bovinos , Iodeto de Dimetilfenilpiperazina/farmacologia , Fenômenos Eletrofisiológicos , Cinética , Mutação/genética , Técnicas de Patch-Clamp , Ligação Proteica , Receptores Nicotínicos/genética , Receptor Nicotínico de Acetilcolina alfa7RESUMO
Nicotinic acetylcholine receptors (nAChRs) transmit the agonist signal to the channel gate through a number of extracellular domains. We have previously shown that particular details of the process of coupling binding to gating could be quantitative and qualitatively different in muscle and neuronal type nAChRs. We have extended previous studies on homomeric alpha7 nAChRs to heteromeric alpha3beta4 nAChRs, by mutating residues located at loops 2 and 7, and M2-M3 linker of both alpha3 and beta4 subunits which, in order to monitor surface expression, were modified to bind alpha-bungarotoxin, and expressed in Xenopus oocytes. We show that, in general, mutations in these domains of both alpha3 and beta4 subunits affect the gating function, although the effects are slightly larger if they are inserted in the alpha3 subunit. However, the involvement of a previously reported intrasubunit interaction in coupling (Gln48-Ile130) seems to be restricted to the beta4 subunit. We also show that mutations at these domains, particularly loop 2 of the alpha3 subunit, change the pharmacological profile of alpha3beta4 nAChRs, decreasing nicotine's and increasing cytisine's effectiveness relative to acetylcholine. It is concluded that, unlike muscle nAChRs, the non-alpha subunits play a relevant role in the coupling process of neuronal alpha3beta4 nAChRs.
Assuntos
Membrana Celular/química , Ativação do Canal Iônico/genética , Receptores Nicotínicos/química , Acetilcolina/metabolismo , Acetilcolina/farmacologia , Animais , Membrana Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Feminino , Humanos , Ativação do Canal Iônico/efeitos dos fármacos , Mutação/genética , Proteínas do Tecido Nervoso/química , Proteínas do Tecido Nervoso/efeitos dos fármacos , Proteínas do Tecido Nervoso/genética , Oócitos , Estrutura Terciária de Proteína/efeitos dos fármacos , Estrutura Terciária de Proteína/genética , Estrutura Terciária de Proteína/fisiologia , Subunidades Proteicas/química , Subunidades Proteicas/efeitos dos fármacos , Subunidades Proteicas/genética , Receptores Nicotínicos/efeitos dos fármacos , Receptores Nicotínicos/genética , Transmissão Sináptica/efeitos dos fármacos , Transmissão Sináptica/genética , Xenopus laevisRESUMO
Recently, we have shown that the alpha-helix present at the N-termini of alpha7 nicotinic acetylcholine receptors plays a crucial role in their biogenesis. Structural data suggest that this helix interacts with the loop linking beta-strands beta2 and beta3 (loop 3). We studied the role of this loop as well as its interaction with the helix in membrane receptor expression. Residues from Asp62 to Val75 in loop 3 were mutated. Mutations of conserved amino acids, such as Asp62, Leu65 and Trp67 abolished membrane receptor expression in Xenopus oocytes. Others mutations, at residues Asn68, Ala69, Ser70, Tyr72, Gly74, and Val 75 were less harmful although still produced significant expression decreases. Steady state levels of wild-type and mutant alpha7 receptors (L65A, W67A, and Y72A) were similar but the formation of pentameric receptors was impaired in the latter (W67A). Mutation of critical residues in subunits of heteromeric nicotinic acetylcholine receptors (alpha3beta4) also abolished their membrane expression. Complementarity between the helix and loop 3 was evidenced by studying the expression of chimeric alpha7 receptors in which these domains were substituted by homologous sequences from other subunits. We conclude that loop 3 and its docking to the alpha-helix is an important requirement for receptor assembly.
Assuntos
Subunidades Proteicas/biossíntese , Subunidades Proteicas/genética , Receptores Nicotínicos/biossíntese , Receptores Nicotínicos/genética , Sequência de Aminoácidos , Substituição de Aminoácidos/genética , Animais , Bovinos , Feminino , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , Proteínas Mutantes Quiméricas/biossíntese , Proteínas Mutantes Quiméricas/genética , Ligação Proteica/genética , Estrutura Secundária de Proteína/genética , Subunidades Proteicas/metabolismo , Receptores Nicotínicos/metabolismo , Xenopus laevis , Receptor Nicotínico de Acetilcolina alfa7RESUMO
We studied the role of the alpha-helix present at the N-terminus of nicotinic acetylcholine receptor (nAChR) subunits in the expression of functional channels. Deletion of this motif in alpha7 subunits abolished expression of nAChRs at the membrane of Xenopus oocytes. The same effect was observed upon substitution by homologous motifs of other ligand-gated receptors. When residues from Gln4 to Tyr15 were individually mutated to proline, receptor expression strongly decreased or was totally abolished. Equivalent substitutions to alanine were less harmful, suggesting that proline-induced break of the alpha-helix is responsible for the low expression. Steady-state levels of wild-type and mutant subunits were similar but the formation of pentameric receptors was impaired in the latter. In addition, those mutants that reached the membrane showed a slightly increased internalization rate. Expression of alpha7 nAChRs in neuroblastoma cells confirmed that mutant subunits, although stable, were unable to reach the cell membrane. Analogous mutations in heteromeric nAChRs (alpha3beta4 and alpha4beta2) and 5-HT(3A) receptors also abolished their expression at the membrane. We conclude that the N-terminal alpha-helix of nAChRs is an important requirement for receptor assembly and, therefore, for membrane expression.
Assuntos
Receptores Nicotínicos/química , Receptores Nicotínicos/fisiologia , Animais , Bungarotoxinas/metabolismo , Bovinos , Linhagem Celular Tumoral , Proteínas de Fluorescência Verde/genética , Leucina/genética , Modelos Moleculares , Mutagênese/fisiologia , Mutação/genética , Neuroblastoma , Oócitos , Prolina/genética , Estrutura Secundária de Proteína/genética , Estrutura Secundária de Proteína/fisiologia , Receptores Nicotínicos/efeitos dos fármacos , Receptores Nicotínicos/genética , Receptores 5-HT3 de Serotonina/genética , Transfecção/métodos , Xenopus , Receptor Nicotínico de Acetilcolina alfa7RESUMO
The existence of axons extending from one retina to the other has been reported during perinatal development in different vertebrates. However, it has been thought that these axons are either a labeling artifact or misprojections. Here, we show unequivocally that a small subset of retinal ganglion cells (RGCs) project to the opposite retina and that the guidance receptor Unc5c, expressed in the retinal region where the retinal-retinal (R-R) RGCs are located, is necessary and sufficient to guide axons to the opposite retina. In addition, Netrin1, an Unc5c ligand, is expressed in the ventral diencephalon in a pattern that is consistent with impeding the growth of Unc5c-positive retinal axons into the brain. We also have generated a mathematical model to explore the formation of retinotopic maps in the presence and absence of a functional connection between both eyes. This model predicts that an R-R connection is required for the bilateral coordination of axonal refinement in species where refinement depends upon spontaneous retinal waves. Consistent with this idea, the retinal expression of Unc5c correlates with the existence and size of an R-R projection in different species and with the extent of axonal refinement in visual targets. These findings demonstrate that active guidance drives the formation of the R-R projection and suggest an important role for these projections in visual mapping to ensure congruent bilateral refinement.
Assuntos
Galinhas/crescimento & desenvolvimento , Furões/crescimento & desenvolvimento , Receptores de Netrina/genética , Retina/fisiologia , Células Ganglionares da Retina/fisiologia , Vias Visuais/crescimento & desenvolvimento , Peixe-Zebra/crescimento & desenvolvimento , Animais , Camundongos/crescimento & desenvolvimento , Receptores de Netrina/metabolismoRESUMO
Acetylcholine α7 nicotinic receptors are widely expressed in the brain, where they are involved in the central processing of pain as well as in neuropsychiatric, neurodegenerative, and inflammatory processes. Positive allosteric modulators (PAMs) show the advantage of allowing the selective regulation of different subtypes of acetylcholine receptors without directly interacting with the agonist binding site. Here, we report the preparation and biological activity of a fluoro-containing compound, 1-(2',5'-dihydroxyphenyl)-3-(2-fluoro-4-hydroxyphenyl)-1-propanone (8, RGM079), that behaves as a potent PAM of the α7 receptors and has a balanced pharmacokinetic profile and antioxidant properties comparable or even higher than well-known natural polyphenols. In addition, compound RGM079 shows neuroprotective properties in Alzheimer's disease (AD)-toxicity related models. Thus, it causes a concentration-dependent neuroprotective effect against the toxicity induced by okadaic acid (OA) in the human neuroblastoma cell line SH-SY5Y. Similarly, in primary cultures of rat cortical neurons, RGM079 is able to restore the cellular viability after exposure to OA and amyloid peptide Aß1-42, with cell death almost completely prevented at 10 and 30 µM, respectively. Finally, compound RGM079 shows in vivo analgesic activity in the complete Freund's adjuvant (CFA)-induced paw inflammation model after intraperitoneal administration.
Assuntos
Regulação Alostérica/efeitos dos fármacos , Analgésicos/farmacologia , Sobrevivência Celular/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Fármacos Neuroprotetores/farmacologia , Dor/tratamento farmacológico , Receptor Nicotínico de Acetilcolina alfa7/metabolismo , Analgésicos/uso terapêutico , Animais , Linhagem Celular Tumoral , Humanos , Inflamação/metabolismo , Neurônios/metabolismo , Dor/metabolismo , Medição da Dor , RatosRESUMO
Binding of agonists to nicotinic acetylcholine receptors (nAChR) is coupled to channel opening through local rearrangements of different domains of the protein. Recent structural data suggest that two of these regions could be the loop 5 (L5) and the beta-strand beta6', both forming the inner part of the N-terminal domain. Amino acids in these domains were mutated in alpha7 nAChRs, and expression levels and functional responses of mutant receptors were measured. Mutations located at the putative apex of L5, Asp97 and Glu98, and also at Phe100, gave receptors with smaller currents, showing qualitative differences with respect to muscle nAChRs. In contrast, mutations in the beta-strand beta6' (at Phe124 and Lys125) showed increased functional responses. Mutations affected equally the responses to acetylcholine and dimethylphenylpiperazinium, except in Phe100 where the latter was sevenfold less effective than in wild-type. Currents in mutants decayed with almost the same kinetics, ruling out large effects on desensitization. Analysis of double mutants demonstrated a functional coupling among the three electrically charged amino acids Asp97, Glu98, and Lys125, and also between Phe100 and Phe124. The results are compatible with the involvement of functional interactions between L5 and beta-strand beta6' during nAChR activation.
Assuntos
Ativação do Canal Iônico/fisiologia , Receptores Nicotínicos/química , Receptores Nicotínicos/fisiologia , Alanina/genética , Substituição de Aminoácidos , Animais , Bungarotoxinas/farmacocinética , Bovinos , Relação Dose-Resposta a Droga , Interações Medicamentosas , Ativação do Canal Iônico/efeitos dos fármacos , Potenciais da Membrana/efeitos dos fármacos , Potenciais da Membrana/genética , Mutação/fisiologia , Agonistas Nicotínicos/farmacocinética , Agonistas Nicotínicos/farmacologia , Oócitos , Ligação Proteica/efeitos dos fármacos , Estrutura Terciária de Proteína/fisiologia , RNA Mensageiro/biossíntese , RNA Mensageiro/genética , Receptor Nicotínico de Acetilcolina alfa7RESUMO
The RIC-3 protein acts as a regulator of acetylcholine nicotinic receptor (nAChR) expression. In Xenopus laevis oocytes the human RIC-3 (hRIC-3) protein enhances expression of alpha7 receptors and abolishes expression of alpha4beta2 receptors. In vitro translation of hRIC-3 evidenced its membrane insertion but not the role as signal peptide of its first transmembrane domain (TMD). When the TMDs of hRIC-3 were substituted, its effects on nAChR expression were attenuated. A certain linker length between the TMDs was also needed for alpha7 expression enhancement but not for alpha4beta2 inhibition. A combination of increased alpha7 receptor steady state levels, facilitated transport and reduced receptor internalization appears to be responsible for the increase in alpha7 membrane expression induced by hRIC-3. Antibodies against hRIC-3 showed its expression in SH-SY5Y and PC12 cells and its induction upon differentiation. Immunohistochemistry demonstrated the presence of RIC-3 in rat brain localized, in general, in places where alpha7 nAChRs were found.
Assuntos
Peptídeos e Proteínas de Sinalização Intracelular/metabolismo , Sistema Nervoso/metabolismo , Receptores Nicotínicos/metabolismo , Sinapses/metabolismo , Transmissão Sináptica/fisiologia , Animais , Encéfalo/anatomia & histologia , Encéfalo/metabolismo , Células COS , Diferenciação Celular/fisiologia , Linhagem Celular Tumoral , Chlorocebus aethiops , Endocitose/fisiologia , Humanos , Peptídeos e Proteínas de Sinalização Intracelular/química , Oócitos , Células PC12 , Estrutura Terciária de Proteína/fisiologia , Transporte Proteico/fisiologia , Ratos , Membranas Sinápticas/metabolismo , Xenopus laevis , Receptor Nicotínico de Acetilcolina alfa7RESUMO
α7 Nicotinic acetylcholine receptors (nAChRs) are ion channels implicated in a number of CNS pathological processes, including pain and psychiatric, cognitive and inflammatory diseases. Comparing with orthosteric agonism, positive allosteric modulation of these channels constitutes an interesting approach to achieve selectivity versus other nicotinic receptors. We have recently described new chalcones and 1,3-diphenylpropanones as positive allosteric modulators (PAMs) of α7 nAChRs, which proved to have good analgesic activities but poor pharmacokinetic properties. Here we report the preparation of amino acid and peptide derivatives as prodrugs of these modulators with the aim of improving their in vivo biological activity. While the valine derivative showed very short half life in aqueous solutions to be considered a prodrug, Val-Val and Val-Pro-Val are suitable precursors of the parent 1,3-diphenylpropanones, via chemical and enzymatic transformation, respectively. Compounds 19 (Val-Val) and 21 (Val-Pro-Val), prodrugs of the 2',5',4-trihydroxy-1,3-diphenylpropan-1-one 3, showed significant antinociceptive activity in in vivo assays. The best compound, 21, displayed a better profile in the analgesia test than its parent compound 3, exhibiting about the same potency but long-lasting effects.
Assuntos
Aminoácidos/farmacologia , Analgésicos/farmacologia , Dor/tratamento farmacológico , Peptídeos/farmacologia , Fenilpropionatos/farmacologia , Pró-Fármacos/farmacologia , Receptor Nicotínico de Acetilcolina alfa7/metabolismo , Regulação Alostérica/efeitos dos fármacos , Aminoácidos/síntese química , Aminoácidos/química , Analgésicos/síntese química , Analgésicos/química , Animais , Relação Dose-Resposta a Droga , Edema/induzido quimicamente , Edema/tratamento farmacológico , Adjuvante de Freund , Humanos , Inflamação/induzido quimicamente , Inflamação/tratamento farmacológico , Masculino , Estrutura Molecular , Medição da Dor , Peptídeos/síntese química , Peptídeos/química , Fenilpropionatos/síntese química , Fenilpropionatos/química , Pró-Fármacos/síntese química , Pró-Fármacos/química , Ratos , Ratos Wistar , Relação Estrutura-Atividade , XenopusRESUMO
Acetylcholine-evoked currents of the receptor chimera alpha7-5HT3A V201 expressed in Xenopus oocytes are strikingly small when compared to the amount of alpha-bungarotoxin binding sites detected at the oocyte membrane. Since the chimeric receptor is made of the extracellular N-terminal region of the rat alpha7 nicotinic acetylcholine receptor and the C-terminal region of the mouse 5-HT3A receptor, which includes the ion channel, we hypothesized that communication between these two regions was not optimal. Here, we show that mutating to aspartate several adjacent positions in the M2-M3 extracellular linker increases current amplitudes to different extents, thus confirming the important role of this region on receptor gating.
Assuntos
Substituição de Aminoácidos , Mutação Puntual , Receptores Nicotínicos/metabolismo , Receptores de Serotonina/metabolismo , Proteínas Recombinantes de Fusão/metabolismo , Animais , Ácido Aspártico/genética , Ácido Aspártico/metabolismo , Bungarotoxinas/farmacologia , Potenciais da Membrana/efeitos dos fármacos , Potenciais da Membrana/genética , Oócitos/metabolismo , Estrutura Secundária de Proteína/genética , Estrutura Terciária de Proteína/genética , Ratos , Receptores Nicotínicos/genética , Receptores de Serotonina/genética , Proteínas Recombinantes de Fusão/genética , Relação Estrutura-Atividade , Xenopus , Receptor Nicotínico de Acetilcolina alfa7RESUMO
Neurotransmitter-gated receptors are assembled in the endoplasmic reticulum and transported to the cell surface through a process that might be of central importance to regulate the efficacy of synaptic transmission (Kneussel and Betz, 2000; Kittler and Moss, 2003). This process is relatively inefficient- what may be the consequence of tight quality controls that guarantee the functional competence of the final product. For this purpose, specific proteins involved in assembly and trafficking of receptors might be required (Keller and Taylor, 1999; Millar, 2003; Wanamaker et al., 2003). The RIC-3 protein could be one of them, as mutations in the ric-3 gene affect maturation of nicotinic acetylcholine receptors (nAChRs) in Caenorhabditis elegans (Halevi et al., 2002). Moreover, the human homolog hRIC-3 showed differential effects when coexpressed with several ligand-gated receptors (Halevi et al., 2003). Thus, it enhanced alpha7 nAChR expression while inhibiting expression of other nAChR subtypes (alpha4beta2 and alpha3beta4) and 5-HT3 serotonin receptors (5-HT3Rs). These opposite effects suggested that the RIC-3 protein might play a key role in the biogenesis of some ligand-gated receptors and prompted us to investigate how it performs its action. Here, we show that the RIC-3 protein acts as a barrier for some receptors like alpha4beta2 nAChRs and 5-HT3Rs, stopping the traffic of mature receptors to the membrane. In contrast, the inefficient transport of alpha7 nAChRs is enhanced by RIC-3 in a process in which certain amino acids at the amphipathic helix located at the C-terminal region of the large cytoplasmic domain are involved.
Assuntos
Peptídeos e Proteínas de Sinalização Intracelular/fisiologia , Receptores Nicotínicos/fisiologia , Receptores de Serotonina/fisiologia , Animais , Células COS , Chlorocebus aethiops , Humanos , Peptídeos e Proteínas de Sinalização Intracelular/genética , Receptores Nicotínicos/biossíntese , Proteínas Recombinantes/metabolismo , TransfecçãoRESUMO
A series of multitarget directed propargylamines, as well as other differently susbstituted piperidines have been screened as potential modulators of neuronal nicotinic acetylcholine receptors (nAChRs). Most of them showed antagonist actions on α7 nAChRs. Especially, compounds 13, 26, and 38 displayed submicromolar IC50 values on homomeric α7 nAChRs, whereas they were less effective on heteromeric α3ß4 and α4ß2 nAChRs (up to 20-fold higher IC50 values in the case of 13). Antagonism was concentration dependent and noncompetitive, suggesting that these compounds behave as negative allosteric modulators of nAChRs. Upon the study of a series of less complex derivatives, the N-benzylpiperidine motif, common to these compounds, was found to be the main pharmacophoric group. Thus, 2-(1-benzylpiperidin-4-yl)-ethylamine (48) showed an inhibitory potency comparable to the one of the previous compounds and also a clear preference for α7 nAChRs. In a neuroblastoma cell line, representative compounds 13 and 48 also inhibited, in a concentration-dependent manner, cytosolic Ca(2+) signals mediated by nAChRs. Finally, compounds 38 and 13 inhibited 5-HT3A serotonin receptors whereas they had no effect on α1 glycine receptors. Given the multifactorial nature of many pathologies in which nAChRs are involved, these piperidine antagonists could have a therapeutic potential in cases where cholinergic activity has to be negatively modulated.